NCT00361738 - Dose-Ranging Study Evaluating AVE2268 in Patients With Type 2 Diabetes Not Adequately Controlled by a Metformin Treatment | Biotech Hunter

Enrollment

317

Participants

Timeline

Start Date

July 31, 2006

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2008

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

AVE2268

Trial Locations (11)

Sanofi-Aventis Administrative Office, San Isidro

Sanofi-Aventis Administrative Office, Cove

Sanofi-Aventis Administrative Office, Diegem

Sanofi-Aventis Administrative Office, Santiago

Sanofi-Aventis Administrative Office, Hørsholm

Sanofi-Aventis Administrative Office, Paris

Sanofi-Aventis Administrative Office, Berlin

Sanofi-Aventis Administrative Office, Milan

Sanofi-Aventis Administrative Office, Gouda

Sanofi-Aventis Administrative Office, Warsaw

Sanofi-Aventis Administrative Office, Midrand